Back to search results

SPI-1005 for the Treatment of Meniere's Disease (Open Label)

Abroad (travel likely)Active Not RecruitingPHASE3

Conditions

Meniere's Disease · Ménière's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The House Institute, Los Angeles, California, United States

  • ENT and Allergy Associates of Florida, Boynton Beach, Florida, United States

  • ENT and Allergy Associates of Florida, Delray Beach, Florida, United States

  • Northwell Health, New Hyde Park, New York, United States

  • ENT and Allergy Associates, LLP, New York, New York, United States

  • Thomas Jefferson University, Philadelphia, Pennsylvania, United States

  • Medical University of South Carolina, Charleston, South Carolina, United States

  • University of Texas Southwestern, Dallas, Texas, United States

  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

View source on ClinicalTrials.gov(opens in a new tab)

No study contact email or phone is listed for this trial.